MAR 16, 2018 10:21 PM PDT

The 'Triple Pill': A New Blood Pressure Treatment

WRITTEN BY: Nouran Amin

Even though there exists an abundance of blood pressure-lowering drugs, high blood pressure persists to be a health concern not only in the US but globally. Blood pressure can lead to heart attacks, kidney issues, as well as stroke; therefore, treating blood pressure is a crucial priority. On a global level, many suffering from high blood-pressure do not get the treatment they need. Many blood-pressure drugs require more than one medication of the treatment regimen. Unfortunately, this increases the complexity of the treatment process causing patients to forget to take their multiple blood-pressure medications.

To fix this issue, a study examined the efficacy of three drugs combined as one combination pill in treating blood pressure and compared these results in usual treatment care. The clinical trial performed was known as the TRIUMPH trial and was conducted in Sri Lanka on patients that have untreated high blood pressure with some having diabetes as well as chronic kidney disease.

Patients enrolled in the study have received either the usual blood pressure care or the combination pill. The combination pill better known as the ‘Triple Pill’ contains three blood pressure drugs: telmisartan, amlodipine, and chlorthalidone. These drugs utilize different blood-pressure reduction mechanisms but, they all work to relax the blood vessels.

The crucial difference between the two categories (triple pill vs. usual care) was the time it took to see results. Patients in the ‘usual care’ category took a longer time to achieve a health blood-pressure target in comparison to the patient receiving the Triple Pill. "Most people — 70 percent — reached blood pressure targets with the Triple Pill,” said study lead author Ruth Webster, MD, of The George Institute for Global Health. “The benefits were seen straight away and maintained until six months, whereas with usual care control rates were 55 percent at six months and even lower earlier in the trial."

Each of the drug used in the Triple Pill was in low dose but effective individually in reducing blood pressure. The particular use of each of these drugs was effective in preventing blood-pressure-related deaths and heart disease. When combining these drugs in the Triple Pill, studies showed that it results in synergistic effects.

The most appealing part of developing the Triple Pill is it’s accessibility in low-income areas as well globally in impoverished areas. It was evaluated as a new tool for care in a real-world setting. "The most urgent need for innovative strategies to control blood pressure is in low- and middle-income countries," says Webster. "The Triple Pill approach is an opportunity to 'leap frog' over traditional approaches to care and adopt an innovative approach that has been shown to be effective."

Lead researchers will conduct a follow-up qualitative study on thoughts concerning the Triple Pill. They will also examine the cost-effectiveness to evaluate if the Triple Pill is a cost-effective solution for controlling blood pressure. Furthermore, if the Triple Pill will serve as a global healthcare drug, then it is important to note that every nation varies on what they consider as a healthy blood pressure target.

Sources: American College of Cardiology, Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 15, 2019
Microbiology
DEC 15, 2019
Potential Therapeutics for Nipah Virus Are Identified
The fatality rate of Nipah virus has an estimated range of 40 to 75 percent...
DEC 17, 2019
Cell & Molecular Biology
DEC 17, 2019
A New Tool for Assessing the Impact of Drugs on Single Cells
When scientists assess the impact of a treatment like a drug on cells, they usually generally rely on large populations of cells to find general trends....
JAN 14, 2020
Drug Discovery & Development
JAN 14, 2020
Can Silica Treat Obesity and Diabetes?
Silica particles, specifically ‘mesoporous silica particles (MSPs)’ are engineered molecular traps that may provide a breakthrough treatment op...
JAN 22, 2020
Cannabis Sciences
JAN 22, 2020
Antibiotic Properties Found in Cannabis Compound
The World Health Organization has identified antibiotic resistance, when bacteria no longer respond to antibiotics, as one of the biggest threats to global...
FEB 10, 2020
Cancer
FEB 10, 2020
New hope for KRAS-mutant pancreatic cancers
A study published recently in the journal Cancer Research showcases the findings from new research on pancreatic cancer. The study was led by Frank Mc...
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Does Traditional Chinese Medicine Work Against Coronavirus?
Over 45,000 cases of Wuhan Coronavirus have been reported globally, alongside over 1,100 deaths. Although over 4,700 people are said to have recovered from...
Loading Comments...